nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—GRIN2B—nerve—hypothyroidism	0.0225	0.153	CbGeAlD
Memantine—GRIN2A—nerve—hypothyroidism	0.0197	0.134	CbGeAlD
Memantine—GRIN2A—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0144	0.0486	CbGpPWpGaD
Memantine—GRIN2A—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0144	0.0486	CbGpPWpGaD
Memantine—Hyperthyroidism—Dextrothyroxine—hypothyroidism	0.0141	0.0253	CcSEcCtD
Memantine—Hyperthyroidism—Levothyroxine—hypothyroidism	0.0141	0.0253	CcSEcCtD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0132	0.0445	CbGpPWpGaD
Memantine—HTR3A—nerve—hypothyroidism	0.013	0.0888	CbGeAlD
Memantine—GRIN1—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0126	0.0424	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0126	0.0424	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of CaMKII—NEFL—hypothyroidism	0.0123	0.0414	CbGpPWpGaD
Memantine—GRIN2B—Unblocking of NMDA receptor, glutamate binding and activation—NEFL—hypothyroidism	0.0123	0.0414	CbGpPWpGaD
Memantine—CYP2C19—urine—hypothyroidism	0.0119	0.0813	CbGeAlD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0115	0.0388	CbGpPWpGaD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—NEFL—hypothyroidism	0.0112	0.0378	CbGpPWpGaD
Memantine—Hyperthyroidism—Liotrix—hypothyroidism	0.0103	0.0186	CcSEcCtD
Memantine—Phlebitis—Liothyronine—hypothyroidism	0.00954	0.0171	CcSEcCtD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00942	0.0317	CbGpPWpGaD
Memantine—Cardiac failure congestive—Liothyronine—hypothyroidism	0.00906	0.0163	CcSEcCtD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00822	0.0277	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—NEFL—hypothyroidism	0.00801	0.027	CbGpPWpGaD
Memantine—DRD2—nerve—hypothyroidism	0.00798	0.0544	CbGeAlD
Memantine—Hypernatraemia—Liotrix—hypothyroidism	0.00778	0.014	CcSEcCtD
Memantine—GRIN2A—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00775	0.0261	CbGpPWpGaD
Memantine—Venous thrombosis—Liotrix—hypothyroidism	0.00758	0.0136	CcSEcCtD
Memantine—GRIN2A—heart—hypothyroidism	0.0073	0.0498	CbGeAlD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00714	0.024	CbGpPWpGaD
Memantine—Angina pectoris—Liothyronine—hypothyroidism	0.00692	0.0124	CcSEcCtD
Memantine—GRIN1—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00676	0.0228	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—NEFL—hypothyroidism	0.00659	0.0222	CbGpPWpGaD
Memantine—SLC22A2—Amine compound SLC transporters—SLC5A7—hypothyroidism	0.00645	0.0217	CbGpPWpGaD
Memantine—Acute coronary syndrome—Liothyronine—hypothyroidism	0.00624	0.0112	CcSEcCtD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00623	0.021	CbGpPWpGaD
Memantine—Myocardial infarction—Liothyronine—hypothyroidism	0.00621	0.0112	CcSEcCtD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—NEFL—hypothyroidism	0.00607	0.0204	CbGpPWpGaD
Memantine—GRIN3A—testis—hypothyroidism	0.0057	0.0388	CbGeAlD
Memantine—GRIN2A—adrenal gland—hypothyroidism	0.00545	0.0371	CbGeAlD
Memantine—Coagulopathy—Liotrix—hypothyroidism	0.00525	0.00944	CcSEcCtD
Memantine—Necrosis—Liotrix—hypothyroidism	0.00521	0.00937	CcSEcCtD
Memantine—Abscess—Liotrix—hypothyroidism	0.00517	0.00929	CcSEcCtD
Memantine—Coma—Levothyroxine—hypothyroidism	0.00508	0.00913	CcSEcCtD
Memantine—Coma—Dextrothyroxine—hypothyroidism	0.00508	0.00913	CcSEcCtD
Memantine—Arrhythmia—Liothyronine—hypothyroidism	0.00508	0.00913	CcSEcCtD
Memantine—GRIN1—cerebellum—hypothyroidism	0.00499	0.034	CbGeAlD
Memantine—SLC22A2—Neurotransmitter Release Cycle—SLC5A7—hypothyroidism	0.00493	0.0166	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00489	0.0165	CbGpPWpGaD
Memantine—Hyperkinesia—Dextrothyroxine—hypothyroidism	0.00485	0.00872	CcSEcCtD
Memantine—Hyperkinesia—Levothyroxine—hypothyroidism	0.00485	0.00872	CcSEcCtD
Memantine—GRIN2B—cerebellum—hypothyroidism	0.00476	0.0324	CbGeAlD
Memantine—Disorientation—Dextrothyroxine—hypothyroidism	0.00451	0.00811	CcSEcCtD
Memantine—Disorientation—Levothyroxine—hypothyroidism	0.00451	0.00811	CcSEcCtD
Memantine—GRIN2A—testis—hypothyroidism	0.00451	0.0307	CbGeAlD
Memantine—Cellulitis—Liotrix—hypothyroidism	0.0045	0.00808	CcSEcCtD
Memantine—Cardiac failure congestive—Dextrothyroxine—hypothyroidism	0.00445	0.008	CcSEcCtD
Memantine—Cardiac failure congestive—Levothyroxine—hypothyroidism	0.00445	0.008	CcSEcCtD
Memantine—Creatinine increased—Liotrix—hypothyroidism	0.0043	0.00772	CcSEcCtD
Memantine—Increased appetite—Dextrothyroxine—hypothyroidism	0.0043	0.00772	CcSEcCtD
Memantine—Increased appetite—Levothyroxine—hypothyroidism	0.0043	0.00772	CcSEcCtD
Memantine—Hypertension—Liothyronine—hypothyroidism	0.00427	0.00768	CcSEcCtD
Memantine—GRIN2A—cerebellum—hypothyroidism	0.00416	0.0284	CbGeAlD
Memantine—Cardiac failure—Dextrothyroxine—hypothyroidism	0.00414	0.00743	CcSEcCtD
Memantine—Hypoglycaemia—Dextrothyroxine—hypothyroidism	0.00414	0.00743	CcSEcCtD
Memantine—Cardiac failure—Levothyroxine—hypothyroidism	0.00414	0.00743	CcSEcCtD
Memantine—Hypoglycaemia—Levothyroxine—hypothyroidism	0.00414	0.00743	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—DLX2—hypothyroidism	0.00407	0.0137	CbGpPWpGaD
Memantine—Affect lability—Dextrothyroxine—hypothyroidism	0.00397	0.00714	CcSEcCtD
Memantine—Affect lability—Levothyroxine—hypothyroidism	0.00397	0.00714	CcSEcCtD
Memantine—Tachycardia—Liothyronine—hypothyroidism	0.00394	0.00709	CcSEcCtD
Memantine—Blood urea increased—Liotrix—hypothyroidism	0.00386	0.00694	CcSEcCtD
Memantine—Irritability—Levothyroxine—hypothyroidism	0.00385	0.00692	CcSEcCtD
Memantine—Irritability—Dextrothyroxine—hypothyroidism	0.00385	0.00692	CcSEcCtD
Memantine—Cardiac arrest—Dextrothyroxine—hypothyroidism	0.00384	0.0069	CcSEcCtD
Memantine—Cardiac arrest—Levothyroxine—hypothyroidism	0.00384	0.0069	CcSEcCtD
Memantine—Mood swings—Levothyroxine—hypothyroidism	0.00382	0.00687	CcSEcCtD
Memantine—Mood swings—Dextrothyroxine—hypothyroidism	0.00382	0.00687	CcSEcCtD
Memantine—GRIN2B—ErbB4 signaling events—PRL—hypothyroidism	0.00378	0.0127	CbGpPWpGaD
Memantine—Hypotension—Liothyronine—hypothyroidism	0.00377	0.00678	CcSEcCtD
Memantine—Dehydration—Levothyroxine—hypothyroidism	0.00375	0.00675	CcSEcCtD
Memantine—Dehydration—Dextrothyroxine—hypothyroidism	0.00375	0.00675	CcSEcCtD
Memantine—Coma—Liotrix—hypothyroidism	0.00374	0.00672	CcSEcCtD
Memantine—HTR3A—blood—hypothyroidism	0.00361	0.0246	CbGeAlD
Memantine—Hyperkinesia—Liotrix—hypothyroidism	0.00357	0.00641	CcSEcCtD
Memantine—Muscular weakness—Dextrothyroxine—hypothyroidism	0.00356	0.0064	CcSEcCtD
Memantine—Muscular weakness—Levothyroxine—hypothyroidism	0.00356	0.0064	CcSEcCtD
Memantine—Sepsis—Liotrix—hypothyroidism	0.00355	0.00638	CcSEcCtD
Memantine—Dysphagia—Levothyroxine—hypothyroidism	0.00349	0.00627	CcSEcCtD
Memantine—Dysphagia—Dextrothyroxine—hypothyroidism	0.00349	0.00627	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00345	0.0116	CbGpPWpGaD
Memantine—Phlebitis—Liotrix—hypothyroidism	0.00345	0.00619	CcSEcCtD
Memantine—Sweating increased—Dextrothyroxine—hypothyroidism	0.0034	0.00611	CcSEcCtD
Memantine—Sweating increased—Levothyroxine—hypothyroidism	0.0034	0.00611	CcSEcCtD
Memantine—Angina pectoris—Levothyroxine—hypothyroidism	0.0034	0.00611	CcSEcCtD
Memantine—Angina pectoris—Dextrothyroxine—hypothyroidism	0.0034	0.00611	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—CLTC—hypothyroidism	0.00336	0.0113	CbGpPWpGaD
Memantine—Disorientation—Liotrix—hypothyroidism	0.00332	0.00597	CcSEcCtD
Memantine—Cardiac failure congestive—Liotrix—hypothyroidism	0.00327	0.00588	CcSEcCtD
Memantine—Renal failure acute—Liotrix—hypothyroidism	0.00322	0.00578	CcSEcCtD
Memantine—Body temperature increased—Liothyronine—hypothyroidism	0.00319	0.00574	CcSEcCtD
Memantine—Increased appetite—Liotrix—hypothyroidism	0.00316	0.00568	CcSEcCtD
Memantine—Weight decreased—Dextrothyroxine—hypothyroidism	0.00316	0.00567	CcSEcCtD
Memantine—Weight decreased—Levothyroxine—hypothyroidism	0.00316	0.00567	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00315	0.0106	CbGpPWpGaD
Memantine—Renal impairment—Liotrix—hypothyroidism	0.00312	0.00561	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00312	0.0105	CbGpPWpGaD
Memantine—Acute coronary syndrome—Dextrothyroxine—hypothyroidism	0.00307	0.00551	CcSEcCtD
Memantine—Acute coronary syndrome—Levothyroxine—hypothyroidism	0.00307	0.00551	CcSEcCtD
Memantine—Myocardial infarction—Levothyroxine—hypothyroidism	0.00305	0.00548	CcSEcCtD
Memantine—Myocardial infarction—Dextrothyroxine—hypothyroidism	0.00305	0.00548	CcSEcCtD
Memantine—Hypoglycaemia—Liotrix—hypothyroidism	0.00304	0.00547	CcSEcCtD
Memantine—Cardiac failure—Liotrix—hypothyroidism	0.00304	0.00547	CcSEcCtD
Memantine—Cerebrovascular accident—Liotrix—hypothyroidism	0.00303	0.00545	CcSEcCtD
Memantine—Affect lability—Liotrix—hypothyroidism	0.00292	0.00525	CcSEcCtD
Memantine—Irritability—Liotrix—hypothyroidism	0.00283	0.00509	CcSEcCtD
Memantine—Cardiac arrest—Liotrix—hypothyroidism	0.00282	0.00507	CcSEcCtD
Memantine—Mood swings—Liotrix—hypothyroidism	0.00281	0.00506	CcSEcCtD
Memantine—Blood creatinine increased—Liotrix—hypothyroidism	0.00278	0.005	CcSEcCtD
Memantine—CYP2A6—liver—hypothyroidism	0.00278	0.0189	CbGeAlD
Memantine—Dehydration—Liotrix—hypothyroidism	0.00276	0.00496	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00272	0.00916	CbGpPWpGaD
Memantine—CYP2A6—cerebellum—hypothyroidism	0.00271	0.0185	CbGeAlD
Memantine—Hypokalaemia—Liotrix—hypothyroidism	0.0027	0.00486	CcSEcCtD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00267	0.009	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00265	0.00893	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—THRB—hypothyroidism	0.00262	0.00883	CbGpPWpGaD
Memantine—Muscular weakness—Liotrix—hypothyroidism	0.00262	0.00471	CcSEcCtD
Memantine—Flushing—Dextrothyroxine—hypothyroidism	0.00259	0.00466	CcSEcCtD
Memantine—Flushing—Levothyroxine—hypothyroidism	0.00259	0.00466	CcSEcCtD
Memantine—Dysphagia—Liotrix—hypothyroidism	0.00257	0.00461	CcSEcCtD
Memantine—Bronchospasm—Liotrix—hypothyroidism	0.00252	0.00454	CcSEcCtD
Memantine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A7—hypothyroidism	0.00252	0.0085	CbGpPWpGaD
Memantine—Sweating increased—Liotrix—hypothyroidism	0.0025	0.00449	CcSEcCtD
Memantine—Angina pectoris—Liotrix—hypothyroidism	0.0025	0.00449	CcSEcCtD
Memantine—Arrhythmia—Dextrothyroxine—hypothyroidism	0.00249	0.00448	CcSEcCtD
Memantine—Arrhythmia—Levothyroxine—hypothyroidism	0.00249	0.00448	CcSEcCtD
Memantine—CYP2B6—adrenal cortex—hypothyroidism	0.00248	0.0169	CbGeAlD
Memantine—DRD2—pituitary gland—hypothyroidism	0.00247	0.0169	CbGeAlD
Memantine—Bronchitis—Liotrix—hypothyroidism	0.00247	0.00444	CcSEcCtD
Memantine—Alopecia—Levothyroxine—hypothyroidism	0.00247	0.00444	CcSEcCtD
Memantine—Alopecia—Dextrothyroxine—hypothyroidism	0.00247	0.00444	CcSEcCtD
Memantine—CYP2B6—heart—hypothyroidism	0.0024	0.0163	CbGeAlD
Memantine—GRIN2A—Neuronal System—SLC5A7—hypothyroidism	0.00239	0.00805	CbGpPWpGaD
Memantine—Tension—Dextrothyroxine—hypothyroidism	0.00238	0.00429	CcSEcCtD
Memantine—Tension—Levothyroxine—hypothyroidism	0.00238	0.00429	CcSEcCtD
Memantine—Nervousness—Levothyroxine—hypothyroidism	0.00236	0.00424	CcSEcCtD
Memantine—Nervousness—Dextrothyroxine—hypothyroidism	0.00236	0.00424	CcSEcCtD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00233	0.00785	CbGpPWpGaD
Memantine—Weight decreased—Liotrix—hypothyroidism	0.00232	0.00417	CcSEcCtD
Memantine—CYP2C19—blood—hypothyroidism	0.00228	0.0156	CbGeAlD
Memantine—Tremor—Dextrothyroxine—hypothyroidism	0.00228	0.00409	CcSEcCtD
Memantine—Tremor—Levothyroxine—hypothyroidism	0.00228	0.00409	CcSEcCtD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—hypothyroidism	0.00227	0.00766	CbGpPWpGaD
Memantine—CYP2B6—cardiovascular system—hypothyroidism	0.00226	0.0154	CbGeAlD
Memantine—Acute coronary syndrome—Liotrix—hypothyroidism	0.00226	0.00405	CcSEcCtD
Memantine—Renal failure—Liotrix—hypothyroidism	0.00225	0.00404	CcSEcCtD
Memantine—Myocardial infarction—Liotrix—hypothyroidism	0.00224	0.00403	CcSEcCtD
Memantine—Agitation—Levothyroxine—hypothyroidism	0.00223	0.00402	CcSEcCtD
Memantine—Agitation—Dextrothyroxine—hypothyroidism	0.00223	0.00402	CcSEcCtD
Memantine—Palpitations—Levothyroxine—hypothyroidism	0.00215	0.00386	CcSEcCtD
Memantine—Palpitations—Dextrothyroxine—hypothyroidism	0.00215	0.00386	CcSEcCtD
Memantine—Convulsion—Levothyroxine—hypothyroidism	0.00211	0.00379	CcSEcCtD
Memantine—Convulsion—Dextrothyroxine—hypothyroidism	0.00211	0.00379	CcSEcCtD
Memantine—GRIN1—Neuronal System—SLC5A7—hypothyroidism	0.00208	0.00702	CbGpPWpGaD
Memantine—Arthralgia—Levothyroxine—hypothyroidism	0.00207	0.00372	CcSEcCtD
Memantine—Arthralgia—Dextrothyroxine—hypothyroidism	0.00207	0.00372	CcSEcCtD
Memantine—Anxiety—Levothyroxine—hypothyroidism	0.00206	0.00371	CcSEcCtD
Memantine—Anxiety—Dextrothyroxine—hypothyroidism	0.00206	0.00371	CcSEcCtD
Memantine—CYP2B6—gonad—hypothyroidism	0.00205	0.014	CbGeAlD
Memantine—Hypoaesthesia—Liotrix—hypothyroidism	0.00204	0.00367	CcSEcCtD
Memantine—GRIN2B—Neuronal System—SLC5A7—hypothyroidism	0.00203	0.00684	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00201	0.00677	CbGpPWpGaD
Memantine—Confusional state—Dextrothyroxine—hypothyroidism	0.002	0.0036	CcSEcCtD
Memantine—Confusional state—Levothyroxine—hypothyroidism	0.002	0.0036	CcSEcCtD
Memantine—Shock—Dextrothyroxine—hypothyroidism	0.00195	0.00351	CcSEcCtD
Memantine—Shock—Levothyroxine—hypothyroidism	0.00195	0.00351	CcSEcCtD
Memantine—Tachycardia—Dextrothyroxine—hypothyroidism	0.00194	0.00348	CcSEcCtD
Memantine—Tachycardia—Levothyroxine—hypothyroidism	0.00194	0.00348	CcSEcCtD
Memantine—Hyperhidrosis—Dextrothyroxine—hypothyroidism	0.00192	0.00345	CcSEcCtD
Memantine—Hyperhidrosis—Levothyroxine—hypothyroidism	0.00192	0.00345	CcSEcCtD
Memantine—Flushing—Liotrix—hypothyroidism	0.00191	0.00343	CcSEcCtD
Memantine—Arrhythmia—Liotrix—hypothyroidism	0.00183	0.0033	CcSEcCtD
Memantine—DRD2—testis—hypothyroidism	0.00183	0.0125	CbGeAlD
Memantine—Alopecia—Liotrix—hypothyroidism	0.00181	0.00326	CcSEcCtD
Memantine—Musculoskeletal discomfort—Levothyroxine—hypothyroidism	0.00181	0.00325	CcSEcCtD
Memantine—Musculoskeletal discomfort—Dextrothyroxine—hypothyroidism	0.00181	0.00325	CcSEcCtD
Memantine—Insomnia—Dextrothyroxine—hypothyroidism	0.00179	0.00323	CcSEcCtD
Memantine—Insomnia—Levothyroxine—hypothyroidism	0.00179	0.00323	CcSEcCtD
Memantine—CYP2B6—adrenal gland—hypothyroidism	0.00179	0.0122	CbGeAlD
Memantine—CYP2B6—blood—hypothyroidism	0.00179	0.0122	CbGeAlD
Memantine—CYP2C19—liver—hypothyroidism	0.00179	0.0122	CbGeAlD
Memantine—Dyspnoea—Levothyroxine—hypothyroidism	0.00177	0.00318	CcSEcCtD
Memantine—Dyspnoea—Dextrothyroxine—hypothyroidism	0.00177	0.00318	CcSEcCtD
Memantine—Flatulence—Liotrix—hypothyroidism	0.00176	0.00317	CcSEcCtD
Memantine—Tension—Liotrix—hypothyroidism	0.00175	0.00315	CcSEcCtD
Memantine—GRIN1—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00175	0.0059	CbGpPWpGaD
Memantine—Dysgeusia—Liotrix—hypothyroidism	0.00175	0.00315	CcSEcCtD
Memantine—Nervousness—Liotrix—hypothyroidism	0.00174	0.00312	CcSEcCtD
Memantine—Fatigue—Levothyroxine—hypothyroidism	0.00171	0.00307	CcSEcCtD
Memantine—Fatigue—Dextrothyroxine—hypothyroidism	0.00171	0.00307	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.00171	0.00575	CbGpPWpGaD
Memantine—DRD2—cerebellum—hypothyroidism	0.00169	0.0115	CbGeAlD
Memantine—Vision blurred—Liotrix—hypothyroidism	0.00168	0.00303	CcSEcCtD
Memantine—Tremor—Liotrix—hypothyroidism	0.00167	0.00301	CcSEcCtD
Memantine—CYP2A6—NRF2 pathway—SLC5A7—hypothyroidism	0.00167	0.00562	CbGpPWpGaD
Memantine—Agitation—Liotrix—hypothyroidism	0.00164	0.00295	CcSEcCtD
Memantine—Feeling abnormal—Levothyroxine—hypothyroidism	0.00163	0.00294	CcSEcCtD
Memantine—Feeling abnormal—Dextrothyroxine—hypothyroidism	0.00163	0.00294	CcSEcCtD
Memantine—GRIN1—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00163	0.00547	CbGpPWpGaD
Memantine—Gastrointestinal pain—Dextrothyroxine—hypothyroidism	0.00162	0.00292	CcSEcCtD
Memantine—Gastrointestinal pain—Levothyroxine—hypothyroidism	0.00162	0.00292	CcSEcCtD
Memantine—Syncope—Liotrix—hypothyroidism	0.0016	0.00288	CcSEcCtD
Memantine—GRIN2B—EPH-Ephrin signaling—VAV3—hypothyroidism	0.00158	0.00534	CbGpPWpGaD
Memantine—Palpitations—Liotrix—hypothyroidism	0.00158	0.00284	CcSEcCtD
Memantine—Urticaria—Dextrothyroxine—hypothyroidism	0.00158	0.00283	CcSEcCtD
Memantine—Urticaria—Levothyroxine—hypothyroidism	0.00158	0.00283	CcSEcCtD
Memantine—Loss of consciousness—Liotrix—hypothyroidism	0.00157	0.00282	CcSEcCtD
Memantine—Abdominal pain—Dextrothyroxine—hypothyroidism	0.00157	0.00282	CcSEcCtD
Memantine—Abdominal pain—Levothyroxine—hypothyroidism	0.00157	0.00282	CcSEcCtD
Memantine—Body temperature increased—Dextrothyroxine—hypothyroidism	0.00157	0.00282	CcSEcCtD
Memantine—Body temperature increased—Levothyroxine—hypothyroidism	0.00157	0.00282	CcSEcCtD
Memantine—Convulsion—Liotrix—hypothyroidism	0.00155	0.00278	CcSEcCtD
Memantine—Hypertension—Liotrix—hypothyroidism	0.00154	0.00277	CcSEcCtD
Memantine—GRIN2A—Neuronal System—NEFL—hypothyroidism	0.00154	0.00519	CbGpPWpGaD
Memantine—Arthralgia—Liotrix—hypothyroidism	0.00152	0.00274	CcSEcCtD
Memantine—Chest pain—Liotrix—hypothyroidism	0.00152	0.00274	CcSEcCtD
Memantine—Anxiety—Liotrix—hypothyroidism	0.00152	0.00273	CcSEcCtD
Memantine—CYP2B6—testis—hypothyroidism	0.00148	0.0101	CbGeAlD
Memantine—Confusional state—Liotrix—hypothyroidism	0.00147	0.00264	CcSEcCtD
Memantine—Oedema—Liotrix—hypothyroidism	0.00146	0.00262	CcSEcCtD
Memantine—Infection—Liotrix—hypothyroidism	0.00145	0.00261	CcSEcCtD
Memantine—Shock—Liotrix—hypothyroidism	0.00144	0.00258	CcSEcCtD
Memantine—Tachycardia—Liotrix—hypothyroidism	0.00142	0.00256	CcSEcCtD
Memantine—Asthenia—Levothyroxine—hypothyroidism	0.00142	0.00256	CcSEcCtD
Memantine—Asthenia—Dextrothyroxine—hypothyroidism	0.00142	0.00256	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—SLC5A7—hypothyroidism	0.00141	0.00476	CbGpPWpGaD
Memantine—Hyperhidrosis—Liotrix—hypothyroidism	0.00141	0.00254	CcSEcCtD
Memantine—Pruritus—Dextrothyroxine—hypothyroidism	0.0014	0.00252	CcSEcCtD
Memantine—Pruritus—Levothyroxine—hypothyroidism	0.0014	0.00252	CcSEcCtD
Memantine—CYP2B6—liver—hypothyroidism	0.0014	0.00952	CbGeAlD
Memantine—Anorexia—Liotrix—hypothyroidism	0.00139	0.0025	CcSEcCtD
Memantine—Hypotension—Liotrix—hypothyroidism	0.00136	0.00245	CcSEcCtD
Memantine—Diarrhoea—Levothyroxine—hypothyroidism	0.00136	0.00244	CcSEcCtD
Memantine—Diarrhoea—Dextrothyroxine—hypothyroidism	0.00136	0.00244	CcSEcCtD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.00135	0.00454	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—NEFL—hypothyroidism	0.00134	0.00452	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Liotrix—hypothyroidism	0.00133	0.00239	CcSEcCtD
Memantine—Insomnia—Liotrix—hypothyroidism	0.00132	0.00237	CcSEcCtD
Memantine—Paraesthesia—Liotrix—hypothyroidism	0.00131	0.00236	CcSEcCtD
Memantine—GRIN2B—Neuronal System—NEFL—hypothyroidism	0.00131	0.00441	CbGpPWpGaD
Memantine—Dyspnoea—Liotrix—hypothyroidism	0.0013	0.00234	CcSEcCtD
Memantine—GRIN1—Axon guidance—CLTC—hypothyroidism	0.00128	0.00432	CbGpPWpGaD
Memantine—Decreased appetite—Liotrix—hypothyroidism	0.00127	0.00228	CcSEcCtD
Memantine—Vomiting—Dextrothyroxine—hypothyroidism	0.00126	0.00227	CcSEcCtD
Memantine—Vomiting—Levothyroxine—hypothyroidism	0.00126	0.00227	CcSEcCtD
Memantine—Fatigue—Liotrix—hypothyroidism	0.00126	0.00226	CcSEcCtD
Memantine—HTR3A—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00126	0.00423	CbGpPWpGaD
Memantine—Rash—Dextrothyroxine—hypothyroidism	0.00125	0.00225	CcSEcCtD
Memantine—Rash—Levothyroxine—hypothyroidism	0.00125	0.00225	CcSEcCtD
Memantine—GRIN2B—Axon guidance—CLTC—hypothyroidism	0.00125	0.00421	CbGpPWpGaD
Memantine—Dermatitis—Levothyroxine—hypothyroidism	0.00125	0.00225	CcSEcCtD
Memantine—Dermatitis—Dextrothyroxine—hypothyroidism	0.00125	0.00225	CcSEcCtD
Memantine—Constipation—Liotrix—hypothyroidism	0.00125	0.00224	CcSEcCtD
Memantine—Headache—Dextrothyroxine—hypothyroidism	0.00124	0.00223	CcSEcCtD
Memantine—Headache—Levothyroxine—hypothyroidism	0.00124	0.00223	CcSEcCtD
Memantine—Feeling abnormal—Liotrix—hypothyroidism	0.0012	0.00216	CcSEcCtD
Memantine—Gastrointestinal pain—Liotrix—hypothyroidism	0.00119	0.00214	CcSEcCtD
Memantine—Nausea—Levothyroxine—hypothyroidism	0.00118	0.00212	CcSEcCtD
Memantine—Nausea—Dextrothyroxine—hypothyroidism	0.00118	0.00212	CcSEcCtD
Memantine—Urticaria—Liotrix—hypothyroidism	0.00116	0.00208	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—VAV3—hypothyroidism	0.00116	0.00389	CbGpPWpGaD
Memantine—Body temperature increased—Liotrix—hypothyroidism	0.00115	0.00207	CcSEcCtD
Memantine—Abdominal pain—Liotrix—hypothyroidism	0.00115	0.00207	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC5A7—hypothyroidism	0.00115	0.00386	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—VAV3—hypothyroidism	0.00113	0.00379	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.00112	0.00376	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—SLC5A7—hypothyroidism	0.00108	0.00365	CbGpPWpGaD
Memantine—Hypersensitivity—Liotrix—hypothyroidism	0.00107	0.00193	CcSEcCtD
Memantine—Asthenia—Liotrix—hypothyroidism	0.00105	0.00188	CcSEcCtD
Memantine—GRIN1—SIDS Susceptibility Pathways—AVP—hypothyroidism	0.00104	0.00352	CbGpPWpGaD
Memantine—Pruritus—Liotrix—hypothyroidism	0.00103	0.00186	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—NKX2-1—hypothyroidism	0.00103	0.00347	CbGpPWpGaD
Memantine—Diarrhoea—Liotrix—hypothyroidism	0.000998	0.00179	CcSEcCtD
Memantine—Dizziness—Liotrix—hypothyroidism	0.000965	0.00173	CcSEcCtD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC26A4—hypothyroidism	0.00095	0.0032	CbGpPWpGaD
Memantine—Vomiting—Liotrix—hypothyroidism	0.000928	0.00167	CcSEcCtD
Memantine—Rash—Liotrix—hypothyroidism	0.00092	0.00165	CcSEcCtD
Memantine—Dermatitis—Liotrix—hypothyroidism	0.000919	0.00165	CcSEcCtD
Memantine—GRIN1—Developmental Biology—CLTC—hypothyroidism	0.000915	0.00308	CbGpPWpGaD
Memantine—Headache—Liotrix—hypothyroidism	0.000914	0.00164	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—NEFL—hypothyroidism	0.000911	0.00307	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CLTC—hypothyroidism	0.000892	0.003	CbGpPWpGaD
Memantine—Nausea—Liotrix—hypothyroidism	0.000867	0.00156	CcSEcCtD
Memantine—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000711	0.0024	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—NEFL—hypothyroidism	0.000698	0.00235	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC5A5—hypothyroidism	0.000668	0.00225	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—VAV3—hypothyroidism	0.000604	0.00203	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—VAV3—hypothyroidism	0.000589	0.00198	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A7—hypothyroidism	0.000583	0.00196	CbGpPWpGaD
Memantine—CYP2A6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000577	0.00194	CbGpPWpGaD
Memantine—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000574	0.00193	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000538	0.00181	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—TRH—hypothyroidism	0.000523	0.00176	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC26A4—hypothyroidism	0.000483	0.00163	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHB—hypothyroidism	0.000466	0.00157	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—TSHR—hypothyroidism	0.000466	0.00157	CbGpPWpGaD
Memantine—CYP2B6—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000465	0.00157	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC5A5—hypothyroidism	0.000458	0.00154	CbGpPWpGaD
Memantine—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—hypothyroidism	0.000434	0.00146	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—VAV3—hypothyroidism	0.000431	0.00145	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000424	0.00143	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—VAV3—hypothyroidism	0.00042	0.00142	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—TRH—hypothyroidism	0.000398	0.00134	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—IYD—hypothyroidism	0.000394	0.00133	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—AVP—hypothyroidism	0.000391	0.00132	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—IYD—hypothyroidism	0.000361	0.00122	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—AVP—hypothyroidism	0.000361	0.00122	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—TSHB—hypothyroidism	0.000355	0.00119	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—TSHR—hypothyroidism	0.000355	0.00119	CbGpPWpGaD
Memantine—CYP2C19—Phase 1 - Functionalization of compounds—POMC—hypothyroidism	0.000352	0.00118	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ATP5O—hypothyroidism	0.000335	0.00113	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TPO—hypothyroidism	0.000315	0.00106	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ATP5O—hypothyroidism	0.000307	0.00103	CbGpPWpGaD
Memantine—CYP2A6—Biological oxidations—POMC—hypothyroidism	0.000306	0.00103	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—IYD—hypothyroidism	0.000292	0.000982	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TPO—hypothyroidism	0.000289	0.000973	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—AVP—hypothyroidism	0.000275	0.000924	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ATP5O—hypothyroidism	0.000248	0.000835	CbGpPWpGaD
Memantine—CYP2B6—Biological oxidations—POMC—hypothyroidism	0.000247	0.000832	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TPO—hypothyroidism	0.000233	0.000785	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC5A5—hypothyroidism	0.000233	0.000784	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—POMC—hypothyroidism	0.000229	0.000773	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TRH—hypothyroidism	0.000225	0.000757	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—IYD—hypothyroidism	0.00022	0.000742	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—AVP—hypothyroidism	0.000209	0.000704	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TRH—hypothyroidism	0.000204	0.000688	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TSHB—hypothyroidism	0.0002	0.000675	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—TSHR—hypothyroidism	0.0002	0.000675	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ATP5O—hypothyroidism	0.000187	0.000631	CbGpPWpGaD
Memantine—CYP2C19—Biological oxidations—POMC—hypothyroidism	0.000187	0.000629	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—AVP—hypothyroidism	0.000183	0.000617	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—POMC—hypothyroidism	0.000182	0.000614	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TSHB—hypothyroidism	0.000182	0.000613	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—TSHR—hypothyroidism	0.000182	0.000613	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TPO—hypothyroidism	0.000176	0.000593	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3C2A—hypothyroidism	0.000163	0.00055	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TSHB—hypothyroidism	0.000146	0.000491	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CLTC—hypothyroidism	0.00014	0.00047	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—POMC—hypothyroidism	0.000139	0.000468	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TSHB—hypothyroidism	0.000134	0.00045	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PIK3C2A—hypothyroidism	0.00013	0.000437	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—VAV3—hypothyroidism	0.000123	0.000413	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TRH—hypothyroidism	0.000121	0.000406	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PIK3C2A—hypothyroidism	0.000119	0.000401	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AVP—hypothyroidism	0.000118	0.000398	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—VAV3—hypothyroidism	0.000111	0.000375	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC5A5—hypothyroidism	0.000109	0.000367	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TSHB—hypothyroidism	0.000108	0.000363	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSHR—hypothyroidism	0.000108	0.000362	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TSHB—hypothyroidism	0.000108	0.000362	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AVP—hypothyroidism	0.000107	0.000361	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC5A5—hypothyroidism	0.0001	0.000337	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PIK3C2A—hypothyroidism	9.62e-05	0.000324	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—SH2B3—hypothyroidism	9.58e-05	0.000323	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TSHB—hypothyroidism	8.16e-05	0.000275	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC5A5—hypothyroidism	8.08e-05	0.000272	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—POMC—hypothyroidism	7.85e-05	0.000264	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—PIK3C2A—hypothyroidism	7.27e-05	0.000245	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—hypothyroidism	7.17e-05	0.000242	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—POMC—hypothyroidism	7.13e-05	0.00024	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PRL—hypothyroidism	7.11e-05	0.000239	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VAV3—hypothyroidism	6.58e-05	0.000221	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AVP—hypothyroidism	6.34e-05	0.000213	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC5A5—hypothyroidism	6.11e-05	0.000206	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—POMC—hypothyroidism	5.71e-05	0.000192	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—POMC—hypothyroidism	5.24e-05	0.000176	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—POMC—hypothyroidism	4.23e-05	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—POMC—hypothyroidism	4.21e-05	0.000142	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—IGF1—hypothyroidism	4.05e-05	0.000136	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—POMC—hypothyroidism	3.19e-05	0.000108	CbGpPWpGaD
